MarketInOut Stock Screener Log In | Sign Up
 

PharmaCyte Biotech Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
PharmaCyte Biotech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3.81 mln
Float10.07 mln
Earnings Date12/18/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

25 / 100
Underperforming

ROE

-44.19
Deeply negative

ROA

-33.58
Deeply negative

Business Description

PharmaCyte Biotech Inc. is a US-based biotechnology company working to bring new cancer treatments to market. Its core approach involves enclosing living cells in a protective cellulose capsule, which then delivers targeted therapy directly to tumors, including hard-to-treat pancreatic cancer. Founded in 1996 and headquartered in Las Vegas, Nevada, the company operates under licensing agreements with partners in Singapore and Austria to advance this technology.

Key Fundamentals

EPS-2.33
ROE-44.19
ROIC-22.59
ROA-33.58
EBITDA, mln-16.15
EV / EBITDA1.50
EV / EBIT1.50

Quote Details

Last 0.3552
Change 0.0052 (1.49%)
Open 0.3471
Volume 44,682
Turnover 15,871
Average Volume 102,092

Financial Ratios

Leverage Ratio1.23
Current Ratio40.30
Price / Book0.16
Price / Tangible Book0.16

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.35
Short % of Float1.32

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.41% 81 / 100   
1 Month -22.17% 20 / 100   
2 Months -43.01% 11 / 100   
6 Months -50.82% 13 / 100   
1 Year -63% 12 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog